<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02991924</url>
  </required_header>
  <id_info>
    <org_study_id>NCC2016-0156</org_study_id>
    <nct_id>NCT02991924</nct_id>
  </id_info>
  <brief_title>Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer</brief_title>
  <official_title>Risk Factors of Medistinal Metastasis in Endoscopic Medistinal Staging of Non-small Cell Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate risk factors for mediastinal lymph node
      metastasis in potentially operable non-small cell lung cancer in order to find indications
      for endoscopic mediastinal staging. Chest CT, integrated PET/CT, and endobronchial ultrasound
      guided transbronchial needle aspiration (EBUS-TBNA) +/- endoscopic ultrasound with
      bronchoscope-guided fine needle aspiration (EUS-B-FNA) are performed for mediastinal staging.
      CT and PET/CT findings, histologic types and other risk factors will be analyzed. The
      investigators develop the prediction method for mediastinal metastasis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2026</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>7 Years</target_duration>
  <primary_outcome>
    <measure>Relative risk of risk factors for mediastinal metastasis</measure>
    <time_frame>When confirmative diagnosis are available in all subjects ;3 years</time_frame>
    <description>risk factors; CT staging (N0-3), PET staging (N0-3), tumor location(central or peripheral), tumor size and histologic types of lung cancer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic values of endoscopic staging</measure>
    <time_frame>When confirmative diagnosis are available in all subjects ;3 years</time_frame>
    <description>sensitivity, negative predictive value, accuracy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>After the diagnosis ; 7 years</time_frame>
    <description>survival after lung cancer treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Molecular test</measure>
    <time_frame>for each subject; up to 60 days, available in all subjects ; 3 years</time_frame>
    <description>EGFR, ALK etc</description>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Non Small Cell Lung Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Non-small cell lung cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed or strongly suspected non-small cell lung cancer (NSCLC)

          -  Potentially operable

        Exclusion Criteria:

          -  M1 disease

          -  Inoperable T4 disease

          -  Mediastinal infiltration or extranodal invasion of the mediastinal lymph node visible
             on chest CT

          -  Confirmed supraclavicular lymph node metastasis

          -  Pancoast tumours

          -  T1 ground glass opacity nodule (with solid part 1&lt;cm)

          -  Solid T1 (1&lt;cm)N0 M0 by CT &amp; PET/CT

          -  Inoperable patients (after evaluating medical and surgical operability)

          -  Patients who refused surgical treatment

          -  Contraindications for bronchoscopy

          -  Drug reaction to lidocaine, midazolam, fentanyl

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bin Hwangbo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hye sook Lee, CRC</last_name>
    <phone>82-31-9201117</phone>
    <email>hbb@ncc.re.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ju- Jae Kim, MD</last_name>
    <phone>82-31-9201115</phone>
    <email>joohaekim@ncc.re.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Cancer Center (NCC) Korea</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi-do</state>
        <zip>410-769</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soonmi Kim, NR</last_name>
      <phone>+82-31-920-0425</phone>
      <email>irb@ncc.re.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2016</study_first_submitted>
  <study_first_submitted_qc>December 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2016</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Bin Hwangbo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>endobronchial ultrasound</keyword>
  <keyword>EBUS-TBNA</keyword>
  <keyword>lung cancer</keyword>
  <keyword>staging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

